Effect of methylene blue and thiol oxidants on pancreatic islet GSH/GSSG ratios and tolbutamide mediated insulin release in vitro

Naunyn Schmiedebergs Arch Pharmacol. 1979 May;307(1):91-6. doi: 10.1007/BF00506556.

Abstract

Methylene blue (an oxidant of NADPH), diamide (an oxidant of glutathion-SH [GSH]) and tertbutyl hydroperoxide (a substrate of glutathione peroxidase) significantly decreased the GSH content of pancreatic rat islets and decreased their GSH/GSSG ratio. They also significantly depressed the single peak insulin response to tolbutamide by the isolated perfused pancreas as well as its synergistic action with glucose in isolated pancreatic islets. These results suggest that the effect of tolbutamide alone and its synergistic action with glucose could depend on the islet NADPH and GSH. In addition it appears that augmentation of tolbutamide action by glucose in insulin release is mediated by the provision of additional NADPH and GSH through glucose metabolism.

MeSH terms

  • Animals
  • Diamide / pharmacology
  • Female
  • Glutathione / metabolism*
  • In Vitro Techniques
  • Insulin / metabolism*
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Methylene Blue / pharmacology*
  • Oxidation-Reduction / drug effects*
  • Peroxides / pharmacology
  • Rats
  • Sulfhydryl Compounds / metabolism*
  • Tolbutamide / pharmacology*

Substances

  • Insulin
  • Peroxides
  • Sulfhydryl Compounds
  • Diamide
  • Tolbutamide
  • Glutathione
  • Methylene Blue